DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

India Glycols Limited — Updates

NSE 3 hrs ago·4 Aug 2026, 12:45 pm

India Glycols

India Glycols Limited has informed the stock exchanges about an update. The company has filed a regulatory disclosure regarding a matter that requires public notice, though the specific details of the event have not been disclosed in the current announcement.

This development is significant for investors as it signals that the company is addressing a corporate event that could impact its operations or financial standing. While the exact nature of the update remains unclear, it is a matter of regulatory compliance that warrants attention from the market.

Investors should monitor the company's subsequent filings or official statements to understand the full context of this update. Keeping an eye on how the stock reacts to this news will also provide insights into market sentiment regarding the development.